Levoxyl and Affect lability - a phase IV clinical study of FDA data

Summary:

Affect lability is reported as a side effect among people who take Levoxyl (levothyroxine sodium), especially for people who are female, 60+ old, have been taking the drug for 10+ years also take Wellbutrin, and have Depression.

The phase IV clinical study analyzes which people have Affect lability when taking Levoxyl. It is created by eHealthMe based on reports of 23,566 people who have side effects when taking Levoxyl from the FDA, and is updated regularly.

What is Levoxyl?

Levoxyl has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 25,178 Levoxyl users. Check the latest studies of Levoxyl.

What is Affect lability?

Affect lability (emotional incontinence) is found to be associated with 666 drugs and 830 conditions by eHealthMe. Check the latest studies of Affect lability.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

23,566 people reported to have side effects when taking Levoxyl.
Among them, 25 people (0.11%) have Affect lability.

Among these 25 people:

How long have people been on Levoxyl when they have Affect lability? *

What is the gender of people who have Affect lability when taking Levoxyl? *

female: 92 %
male: 8 %

What is the age of people who have Affect lability when taking Levoxyl? *

What are other drugs people take besides Levoxyl? *

What are other side effects people have besides Affect lability? *

Stress And Anxiety: 13 people, 52.00%
Agitation (state of anxiety or nervous excitement): 11 people, 44.00%
Tearfulness (excess tearing): 8 people, 32.00%
Feeling Abnormal: 8 people, 32.00%
Confusional State: 8 people, 32.00%
Pain: 7 people, 28.00%
Drug Ineffective: 7 people, 28.00%
Inappropriate Affect: 7 people, 28.00%
Malaise (a feeling of general discomfort or uneasiness): 6 people, 24.00%
Retroperitoneal Haemorrhage (bleeding between the peritoneum and the posterior abdominal wall): 6 people, 24.00%

What are the existing conditions these people have? *

Depression: 14 people, 56.00%
Back Pain: 7 people, 28.00%
Irritable Bowel Syndrome: 6 people, 24.00%
Nail Disorder (disease of nail): 6 people, 24.00%
Arthropathy: 6 people, 24.00%
Gastritis (inflammation of stomach): 6 people, 24.00%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 6 people, 24.00%
Hair Disorder: 6 people, 24.00%
Headache (pain in head): 6 people, 24.00%
Intervertebral Disc Protrusion (spinal disc protrusion): 6 people, 24.00%

* Approximation only. Some reports may have incomplete information.

Do you take Levoxyl and have Affect lability?

- Check whether Affect lability is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Levoxyl:

Levoxyl (25,178 reports)

Affect lability treatments and more:

Affect lability (13,491 reports)

Browse all side effects of Levoxyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Affect lability:

Affect lability (666 drugs)

Browse all the conditions that are associated with Affect lability:

Affect lability (830 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on levothyroxine sodium (the active ingredients of Levoxyl) and Levoxyl (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.